v3.21.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 151,097 $ 200,404
Short-term investments 284,064 300,255
Restricted cash - short-term 194 194
Accounts receivable 9,610 1,250
Prepaid expenses and other current assets 19,342 21,170
Total current assets 464,307 523,273
Property and equipment, net 51,471 50,517
Operating lease assets 11,930 12,303
Restricted cash - long-term 1,200 1,200
Other assets 729 827
Total assets 529,637 588,120
Current liabilities:    
Accounts payable 17,355 7,118
Accrued compensation 12,786 20,458
Accrued research and development expenses 10,655 15,813
Deferred revenue 35,497 33,455
Other current liabilities 7,901 6,057
Total current liabilities 84,194 82,901
Deferred revenue - long-term 31,811 27,795
Operating lease liabilities - long-term 12,569 13,041
Other long-term liabilities 2,026 2,044
Total liabilities 130,600 125,781
Commitments and contingencies (Note 8)
Stockholders’ equity:    
Common stock—$0.0001 par value, 500,000 shares authorized as of March 31, 2021 and December 31, 2020; 84,075 and 83,372 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively 8 8
Additional paid-in capital 1,601,784 1,586,616
Accumulated other comprehensive income 161 296
Accumulated deficit (1,202,916) (1,124,581)
Total stockholders’ equity 399,037 462,339
Total liabilities and stockholders’ equity $ 529,637 $ 588,120

Source